ALK and non-small cell lung carcinoma: Gao et al. showed that patients with NSCLC have a positive rate of ALK up to 9.0% and between 2.4% and 8.8% in early stage patients [59], which is consistent with the results of this study that the positive rate is higher is in the early stage patients.